Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
14 pending office actions • 11 clients • 14 examiners • 10 art units • 0 of 14 (0%) have an AI response strategy ready
Lewis Kohn & Walker LLP manages a portfolio in Biotechnology & Pharmaceuticals with 680 career applications. The firm maintains a resolved allowance rate of 90.24 percent for applications that reach a final resolution. Achieving these results involves an average of 3.33 office actions per allowance. Currently, the firm has 13 pending office actions to address.
The 680 career applications and 90.24 percent allowance rate reflect the firm's practice in its primary technology area. The 3.33 average office actions per allowance provides a benchmark for expected examiner interaction during the patent acquisition process. These figures offer a data-grounded view of the firm's historical performance and current workload for practitioners evaluating the firm's Biotechnology & Pharmaceuticals experience.
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (7%) |
| §103 only | 4 (29%) |
| §112 only | 1 (7%) |
| Double-patenting only | 1 (7%) |
| Double-patenting + other | 2 (14%) |
| Multi-statute (no §101) | 5 (36%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHI, KATHERINE MENGLIN | 1 | 78.4% | +21.7% |
| YU, HONG | 1 | 30.9% | +5.6% |
| SHEWAREGED, BETELHEM | 1 | 71.6% | +9.2% |
| LEE, SIN J | 1 | 68.8% | +25.1% |
| SOROUSH, ALI | 1 | 47.0% | +30.8% |
| MCWILLIAMS, KELSEY LYNN | 1 | 88.9% | +5.8% |
| SIEFKE, SAMUEL P | 1 | 63.1% | +17.8% |
| GILL, RACHEL B | 1 | 65.6% | +28.3% |
| KUMAR, RAKESH | 1 | 57.2% | +28.2% |
| PHAN, DOAN THI-THUC | 1 | 42.7% | +47.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18017752 | Antibody/Adjuvant Compositions and Methods of Immune Response Generation against Coronaviruses | GILL, RACHEL B | 125d overdue |
| 17840451 | CARTRIDGES, DISPENSERS, AND KITS FOR DISPENSING INSTRUMENT COVERS | KUMAR, RAKESH | 52d overdue |
| 18634811 | VALIDATION OF DEGREE OF CURE WITH UV RADIATION BY MEANS OF FLUORESCING WITH EXPOSURE TO UV LIGHT | SHEWAREGED, BETELHEM | 12d |
| 19112519 | Endoscopic Tool | SHI, KATHERINE MENGLIN | — |
| 18726759 | Aqueous Composition Comprising Avermectins | YU, HONG | — |
| 18271400 | Epichloe Endophyte | MCWILLIAMS, KELSEY LYNN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18017752 | Antibody/Adjuvant Compositions and Methods of Immune Response Generation against Coronaviruses | GILL, RACHEL B | 125d overdue |
| 18439657 | Methods, Compositions and Devices Related to Seaweed Masks | LEE, SIN J | 58d overdue |
| 17840451 | CARTRIDGES, DISPENSERS, AND KITS FOR DISPENSING INSTRUMENT COVERS | KUMAR, RAKESH | 52d overdue |
| 17423669 | Covered Stent For Local Drug Delivery | PHAN, DOAN THI-THUC | 23d overdue |
| 19112519 | Endoscopic Tool | SHI, KATHERINE MENGLIN | — |
| 18273708 | Materials and Methods for Treating Viral and Other Medical Conditions | SOROUSH, ALI | — |
| 18029017 | SAMPLE CONTAINER THAT CAN BE CLOSED WITH A NONWOVEN FABRIC, USE OF THE SAMPLE CONTAINER FOR DRYING AND PROCESSING THE SAMPLE OF A BIOLOGICAL MATERIAL, AND METHOD FOR PROCESSING THE SAMPLE | SIEFKE, SAMUEL P | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Biotronik SE & Co. KG | 3 |
| Vascular Biosciences | 2 |
| Nmgn Medical | 1 |
| Hwi Pharma Services GmbH | 1 |
| Sunrez Corporation | 1 |
| Laclede | 1 |
| GRASSLANZ TECHNOLOGY LIMITED | 1 |
| Abf Diagnostics GmbH | 1 |
| University of Hawaii | 1 |
| Aseptiscope | 1 |
| WOOL RESEARCH ORGANISATION OF NEW ZEALAND INCORPORATED | 1 |
| Art Unit | Apps |
|---|---|
| 1613 | 3 |
| 1614 | 2 |
| 1785 | 1 |
| 1663 | 1 |
| 1758 | 1 |
| 1671 | 1 |
| 3651 | 1 |
| 1629 | 1 |
| 1658 | 1 |
| 1637 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19112519 | Endoscopic Tool | Nmgn Medical | SHI, KATHERINE MENGLIN | §102§112 | Non-Final OA | — | Pending | Mar 17, 2025 | |
| 18726759 | Aqueous Composition Comprising Avermectins | Hwi Pharma Services GmbH | YU, HONG | 1614 | §103§112 | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18634811 | VALIDATION OF DEGREE OF CURE WITH UV RADIATION BY MEANS OF FLUORESCING WITH EXPOSURE TO UV LIGHT | Sunrez Corporation | SHEWAREGED, BETELHEM | 1785 | §102§112 | Final Rejection | 12d | Pending | Apr 12, 2024 |
| 18439657 | Methods, Compositions and Devices Related to Seaweed Masks | Laclede, Inc. | LEE, SIN J | 1613 | §103 | Final Rejection | 58d overdue | Pending | Feb 12, 2024 |
| 18273708 | Materials and Methods for Treating Viral and Other Medical Conditions | BIOTRONIK SE & Co. KG | SOROUSH, ALI | 1614 | §103 | Non-Final OA | — | Pending | Jul 21, 2023 |
| 18271400 | Epichloe Endophyte | Grasslanz Technology Limited | MCWILLIAMS, KELSEY LYNN | 1663 | §101§112 | Non-Final OA | — | Pending | Jul 07, 2023 |
| 18029017 | SAMPLE CONTAINER THAT CAN BE CLOSED WITH A NONWOVEN FABRIC, USE OF THE SAMPLE CONTAINER FOR DRYING AND PROCESSING THE SAMPLE OF A BIOLOGICAL MATERIAL, AND METHOD FOR PROCESSING THE SAMPLE | Abf Diagnostics GmbH | SIEFKE, SAMUEL P | 1758 | §103 | Final Rejection | — | Pending | Mar 28, 2023 |
| 18017752 | Antibody/Adjuvant Compositions and Methods of Immune Response Generation against Coronaviruses | UNIVERSITY OF HAWAII | GILL, RACHEL B | 1671 | §102§103§112 | Non-Final OA | 125d overdue | Pending | Jan 24, 2023 |
| 17840451 | CARTRIDGES, DISPENSERS, AND KITS FOR DISPENSING INSTRUMENT COVERS | Aseptiscope, Inc. | KUMAR, RAKESH | 3651 | §103§112 | Non-Final OA | 52d overdue | Pending | Jun 14, 2022 |
| 17423669 | Covered Stent For Local Drug Delivery | BIOTRONIK SE & Co. KG | PHAN, DOAN THI-THUC | 1613 | §103§112DP | Non-Final OA | 23d overdue | Pending | Jul 16, 2021 |
| 17264755 | Keratin Compositions | Wool Research Organisation Of New Zealand Incorporated | CHANG, KYUNG SOOK | 1613 | §103 | Non-Final OA | 46d overdue | Pending | Jan 29, 2021 |
| 16975043 | PARENTERAL FORMULATION MATERIALS AND METHODS FOR 40-O-CYCLIC HYDROCARBON ESTERS AND RELATED STRUCTURES | BIOTRONIK SE & Co. KG | BORI, IBRAHIM D | 1629 | §103DP | Non-Final OA | — | Pending | Aug 21, 2020 |
| 16998489 | Methods for Increasing the Selective Efficacy of Gene Therapy Using CAR Peptide and Heparan-Sulfate Mediated Macropinocytosis | Vascular Biosciences | REYNOLDS, FRED H | 1658 | §112 | Final Rejection | 85d overdue | Pending | Aug 20, 2020 |
| 16908540 | Methods of Novel Therapeutic Candidate Identification Through Gene Expression Analysis in Vascular-Related Diseases | Vascular Biosciences | POLIAKOVA-GEORGAN, EKATERINA | 1637 | DP | Final Rejection | 37d overdue | Pending | Jun 22, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial